We've tried to summarize the data from some of the stock subreddits here into different categories. The categories are Recent Posts, Due Diligence (DD), Discussions or News. The News here is usually not the news in media but still very relevant information.
| Date | Title | Subreddit | Price |
|---|---|---|---|
| Mar-20-2022 | Humanigen, Inc. (HGEN) and what does CSO know. | stocks | 3.97 |
| Mar-17-2022 | SEC Form 4: Chappell Dale bought $3,000,000 worth of shares (1,000,000 units at $3.00) $HGEN | StockMarket | 3.47 |
| Mar-17-2022 | Humanigen is the move. Top line data from ACTIV-5 to be released in the coming weeks. Heavy insider buys. 11% short interest. Small float. $HGEN | Shortsqueeze | 3.47 |
| Dec-30-2021 | 68.1%, You may win big. | stocks | 3.75 |
| Dec-01-2021 | $HGEN publishes results results showing significant improvement in COVID survival rate using their treatment | stocks | 5.57 |
| Nov-26-2021 | $HGEN Lenzilumab Covid19 drug now on Phase 3 | Shortsqueeze | 6.11 |
| Nov-22-2021 | HGEN | Shortsqueeze | 5.80 |
| Sep-22-2021 | Does HGEN have potential | stocks | 6.35 |
| Sep-19-2021 | Karyopharm ($KPTI) Bull & Bear Investment Thesis | FluentInFinance | 6.83 |
| Sep-09-2021 | FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in Hospitalized COVID-19 Patients | wallstreetbetsOGs | 15.11 |
| Date | Title | Subreddit | Price |
|---|---|---|---|
| Mar-17-2022 | SEC Form 4: Chappell Dale bought $3,000,000 worth of shares (1,000,000 units at $3.00) $HGEN | StockMarket | 3.47 |
| Sep-01-2021 | Leak Humanigen Investigator meeting. Gets good around 19 minutes. Talk of FDA EUA around 31 minutes. | StockMarket | 16.58 |
| Apr-04-2021 | I built a program that tracks mentions and sentiment of stocks across Reddit and Twitter! This week's most discussed and top growing stocks! | wallstreetbets | 19.21 |
| Mar-29-2021 | (3/29) Monday's Pre-Market Stock Movers & News | StockMarket | 21.61 |
| Mar-29-2021 | ($HGEN) Humanigen Reports Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ | stocks | 21.61 |